HU166029B - - Google Patents

Info

Publication number
HU166029B
HU166029B HUTA1257A HUTA001257A HU166029B HU 166029 B HU166029 B HU 166029B HU TA1257 A HUTA1257 A HU TA1257A HU TA001257 A HUTA001257 A HU TA001257A HU 166029 B HU166029 B HU 166029B
Authority
HU
Hungary
Application number
HUTA1257A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU166029B publication Critical patent/HU166029B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HUTA1257A 1972-07-01 1973-06-01 HU166029B (enrdf_load_html_response)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (enrdf_load_html_response) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
HU166029B true HU166029B (enrdf_load_html_response) 1974-12-28

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
HUTA1257A HU166029B (enrdf_load_html_response) 1972-07-01 1973-06-01

Country Status (15)

Country Link
US (1) US3925357A (enrdf_load_html_response)
JP (1) JPS5512435B2 (enrdf_load_html_response)
AT (1) AT325206B (enrdf_load_html_response)
AU (1) AU469986B2 (enrdf_load_html_response)
BE (1) BE801588A (enrdf_load_html_response)
CA (1) CA996548A (enrdf_load_html_response)
CH (1) CH573435A5 (enrdf_load_html_response)
CS (1) CS168036B2 (enrdf_load_html_response)
DE (1) DE2332840A1 (enrdf_load_html_response)
FR (1) FR2190414B1 (enrdf_load_html_response)
GB (1) GB1386566A (enrdf_load_html_response)
HU (1) HU166029B (enrdf_load_html_response)
NL (1) NL7308048A (enrdf_load_html_response)
PL (1) PL92969B1 (enrdf_load_html_response)
SE (1) SE402916B (enrdf_load_html_response)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (enrdf_load_html_response) * 1978-07-29 1980-02-13
SI1368349T1 (sl) * 2001-02-24 2007-06-30 Boehringer Ingelheim Pharma Ksantinski derivati, njihova priprava in njihova uporaba kot zdravila
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CA2873524C (en) 2006-05-04 2018-02-20 Boehringer Ingelheim International Gmbh A polymeric form of 1-((4-methyl-quinazolin-2-yl)methyl)-3-7-(2-butyn-1-yl)-8-(3-(r)-aminopiperidin-1-yl)xanthine
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP3542801A1 (en) * 2007-08-17 2019-09-25 Boehringer Ingelheim International GmbH Purin derivatives for use in the treatment of fap-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
MY164581A (en) * 2008-08-15 2018-01-15 Boehringer Ingelheim Int Purin derivatives for use in the treatment of fab-related diseases
CA2736421A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
NZ592924A (en) 2008-12-23 2014-05-30 Boehringer Ingelheim Int Salt forms of a xanthine derivative
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EA034869B1 (ru) 2009-11-27 2020-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
AU2011249722B2 (en) 2010-05-05 2015-09-17 Boehringer Ingelheim International Gmbh Combination therapy
KR20200028498A (ko) 2010-06-24 2020-03-16 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
WO2013010964A1 (en) 2011-07-15 2013-01-24 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP6615109B2 (ja) 2014-02-28 2019-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｄｐｐ−４阻害薬の医学的使用
JP2019517542A (ja) 2016-06-10 2019-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング リナグリプチンおよびメトホルミンの組合せ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (enrdf_load_html_response) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
JPS5512435B2 (enrdf_load_html_response) 1980-04-02
CH573435A5 (enrdf_load_html_response) 1976-03-15
AU469986B2 (en) 1976-02-26
FR2190414B1 (enrdf_load_html_response) 1976-07-02
US3925357A (en) 1975-12-09
BE801588A (fr) 1973-12-28
CA996548A (en) 1976-09-07
NL7308048A (enrdf_load_html_response) 1974-01-03
CS168036B2 (enrdf_load_html_response) 1976-05-28
FR2190414A1 (enrdf_load_html_response) 1974-02-01
GB1386566A (en) 1975-03-12
PL92969B1 (enrdf_load_html_response) 1977-04-30
JPS4925121A (enrdf_load_html_response) 1974-03-06
SE402916B (sv) 1978-07-24
AU5760073A (en) 1975-01-09
DE2332840A1 (de) 1974-01-17
AT325206B (de) 1975-10-10

Similar Documents

Publication Publication Date Title
FR2190414B1 (enrdf_load_html_response)
FR2271492A1 (enrdf_load_html_response)
FR2174827A1 (enrdf_load_html_response)
FR2168134B2 (enrdf_load_html_response)
JPS546682Y2 (enrdf_load_html_response)
JPS48100537U (enrdf_load_html_response)
JPS4928135A (enrdf_load_html_response)
JPS497265A (enrdf_load_html_response)
JPS48103733U (enrdf_load_html_response)
JPS4961832U (enrdf_load_html_response)
FR2174246A1 (enrdf_load_html_response)
JPS48102390U (enrdf_load_html_response)
JPS4934054U (enrdf_load_html_response)
JPS4979657U (enrdf_load_html_response)
CH591094A5 (enrdf_load_html_response)
CH585002A5 (enrdf_load_html_response)
CH1851972A4 (enrdf_load_html_response)
BG26793A1 (enrdf_load_html_response)
CH582624A5 (enrdf_load_html_response)
CH376172A4 (enrdf_load_html_response)
BG22750A1 (enrdf_load_html_response)
BG18653A1 (enrdf_load_html_response)
SE373815B (enrdf_load_html_response)
CH561916A5 (enrdf_load_html_response)
CH545656A (enrdf_load_html_response)